Next Article in Journal
Unveiling Natural and Semisynthetic Acylated Flavonoids: Chemistry and Biological Actions in the Context of Molecular Docking
Previous Article in Journal
Recent Trends in the Preparation of Nano-Starch Particles
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Twelve New Seco-Pregnane Glycosides from Cynanchum taihangense

1
School of Pharmacy, Jinzhou Medical University, Jinzhou 121001, China
2
School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China
3
Research & Development Center, Zhejiang Xianju Pharmaceutical Co., Ltd., Taizhou 317300, China
4
Key Laboratory of Food Safety Research in Qinghai Province, Xining Customs District, Xining 810003, China
*
Authors to whom correspondence should be addressed.
This author is the first corresponding author and Jinzhou Medical University is the first corresponding affiliation.
Molecules 2022, 27(17), 5500; https://doi.org/10.3390/molecules27175500
Submission received: 20 July 2022 / Revised: 19 August 2022 / Accepted: 22 August 2022 / Published: 26 August 2022

Abstract

:
For our interest in the potential biologically active and structurally unique steroidal glycosides, continued phytochemical investigation of Cynanchum taihangense was carried out; twelve new seco-pregnane glycosides, cynataihosides I–L (14), M-T (714), and two known glycosides, glaucoside A (5) and atratcynoside F (6), were isolated from the 95% ethanol extract of Cynanchum taihangense. Two new aglycones were found among compounds 10, 11, 13, and 14. The structures of the glycosides were elucidated based on 1D and 2D NMR spectroscopic data, HR-ESI-MS analysis, and chemical evidence. The cytotoxicity of compounds against three human tumor cell lines (HL-60, THP-1, and PC-3) were evaluated by MTT assay. Compound 11 displayed significant cytotoxicity against THP-1 and PC-3 cell line with IC50 values of 5.08 and 22.75 μm, respectively. Compounds 3 and 14 exhibited moderate and selective cytotoxicity on HL-60 and THP-1 with IC50 values of 17.78 and 16.02 μm, respectively.

Graphical Abstract

1. Introduction

The chemical structures of C21 steroidal glycosides were classified into polyhydroxypregnane-type and seco-pregnae-type glycosides [1,2,3]. Seco-pregnane glycosides, as one higher oxidation degree type of C21 steroidal glycosides with extensive biological activities, have been found in Sect. Vincetoxicum of Cynanchum which includes many plants used in traditional Chinese medicine [4,5,6,7,8,9]. Cynanchum taihangense (“Tai-Hang-Bai-Qian” in Chinese) is a herbaceous plant and is chiefly distributed in Shanxi Province, China [10]. To investigate the potential pregnane glycosides chemical structure of the plant and their activity, we studied the 95% EtOH extract of Cynanchum taihangense (C. taihangense) previously [11,12,13]. Here, we further report twelve new pregnane glycosides, namely, cynataihosides I–L (14), M–T (714), with totally two new and four known types of aglycones, and two known glycosides, glaucoside A (5) and atratcynoside F (6), which were obtained from the continued phytochemical research of C. taihangense. Their structures are shown in Figure 1. The structural elucidation of new compounds and cytotoxicity of all compounds for human cancer cell lines (HL-60, THP-1, and/or PC-3) are described.

2. Results and Discussion

The fresh plants of C. taihangense were extracted with 95% ethanol. After concentration, the water suspension of the extraction was partitioned with petroleum ether, ethyl acetate, and n-butanol, successively. Then, the ethyl acetate and n-butanol extract were subjected to various chromatographic isolation methods, respectively, to give twelve new and two known seco-pregnane glycosides. Their structures and the absolute configurations were elucidated by analysis of 1D/2D NMR spectroscopic data, HR-ESI-MS analysis, and chemical evidence (Supplementary Figures S1–S88).

2.1. Structure Elucidation

Cynataihoside I (1) was afforded as light yellow amorphous gum, [α ] D 20 −33.18° (c 0.75, MeOH). Its positive HR-ESI-MS showed an ion peak at m/z 993.4678 [M + Na]+ (calculated (calcd) for C48H74NaO20, 993.4671), indicating a molecular formula of C48H74O20. The 1H NMR spectrum of 1 displayed characteristic signals of steroidal glycoside with a 13,14:14,15-disecopregnane-type skeleton aglycone: two tertiary methyl groups (δH 0.89 (3H, s, H-19) and 1.53 (3H, s, H-21)), an oxygen-substituted methine proton (δH 5.43 (1H, m), H-16)), one olefinic proton (δH 5.41 (1H, m, H-6)), and one olefinic deshielded proton (6.47 (1H, s, H-18)). The 1H and 13C NMR signals were assigned by the HSQC spectrum. The HMBC cross-peaks of H-19/C-10, C-1, C-9, and C-5 indicated the connection of rings A and B. Furthermore, correlations of H-21/C-20, C-21, and C-17 were observed. HMBC correlations from δH 5.41 (H-6) to δC 28.2 (C-7), 37.3 (C-4), 39.2 (C-10), and 40.0 (C-8), and from δH 6.47 (H-18) to δC 114.1 (C-13), 23.6 (C-12), 55.9 (C-17), and 118.3 (C-20) proved the presence of the Δ5–6 and Δ13–18 olefinic groups. Interactions from δH 2.47 (H-8) and 5.43 (H-16) to δC 175.1 (C-14), though 2JCH and 3JCH, respectively, verified that C-16 of the furan ring and C-8 were connected through an ester carbonyl group (Figure 2). Further HMBC spectrum detailed analysis confirmed the structure of the aglycone (Figure 2). The 1H and 13C NMR data (Table 1) of the aglycone part of 1 were basically consistent with a known steroidal aglycone, glaucogenin A [14], except for the glycosidation shifts at C-2 (−2.5), C-3 (+8.7), and C-4 (−2.6). In addition, the data were almost the same as those of glaucogenin A in sublanceoside B2 [15], which implied that 1 was glaucogenin A linked to a sugar chain at its C-3 hydroxyl group. The 13C NMR data of the sugar moiety of 1 were virtually identical to those of cynamooreoside H [16]. Thus, it was assumed that 1 possessed four sugar units and the sequences were β-D-glucopyranosyl-(1→4)-L-diginopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranosyl. These were supported by spectroscopic analyses and acid hydrolysis. The linkage of the four sugars were determined by HMBC correlations from δH 4.96 (H-1′′′′ of β-glucopyranose) to δC 74.1 (C-4′′′ of α-diginopyranose), from δH 5.20 (H-1′′′ of α-diginopyranose) to δC 82.0 (C-4′′ of β-cymaropyranose), from δH 5.05 (H-1′′ of β-cymaropyranose) to δC 82.7 (C-4′ of β-cymaropyranose), and from δH 5.18 (H-1′ of β-cymaropyranose) to δC 85.2 (C-3) (Figure 2). On acid hydrolysis, 1 gave cymarose, diginose, and glucose. In addition, the orientations of the aglycone and sugars were elucidated through the NOESY experiments: H-19/H-8, H-2 (β-orientated); H-17/H-16 and H-21 (α-orientated); H-1′/H-3, H-5′, and C-3′-OCH3 (α-orientated); H-1′′/H-5′′ (α-orientated); H-3ʹʹʹ/H-5ʹʹʹ (β-orientated); H-1ʹʹʹʹ/ H-3ʹʹʹʹ, H-5ʹʹʹʹ (β-orientated) (Figure 2). Thus, the structure of 1 was established as glaucogenin A 3-O-β-D-glucopyranosyl-(1→4)-L-diginopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, and named cynataihoside I.
Cynataihoside J (2) was isolated as light yellow amorphous gum. Its molecular structure was deduced as C47H72O20 based on a quasi-molecular ion peak at m/z 979.4509 (calcd, 979.4515) for [M + Na]+ ion in the HR-ESI-MS data. Detailed analysis of 1H and 13C NMR spectra revealed that the structure of 2 was similar to that of compound 1, and the difference was only in the second sugar, which was attached to the first cymarose. A comparison of the NMR data of 2 with those of cynataihoside C [11] indicated that they had the same aglycone and two inside deoxysugars, β-D-digitoxopyranosyl-(1→4)-β-D-cymaropyranosyl, linked at the C-3 hydroxyl group. Thus, the sugar unit different from compound 1 was supposed to be β-D-digitoxopyranosyl. Acid hydrolysis of 2 afforded four sugars: cymarose, digitoxose, diginose, and glucose. The sugar sequence and the linkage sites to the aglycone moiety of 2 were demonstrated by the HMBC correlations between H-1′-Cym (δH 5.19) and C-3 (δC 85.2); H-1′′-Dgt (δH 5.32) and C-4′-Cym (δC 82.7); H-1′′′-Dgn (δH 5.27) and C-4′′-Dgt (δC 82.0); H-1′′′′-Glc (δH 4.94) and C-4′′′-Dgn (δC 74.4). In the NOESY spectrum, correlations for H-19 to H-2 (β-orientated), for H-17 to H-21 (α-orientated), for H-1ʹ to H-5ʹ (α-orientated), for H-1ʹʹ to H-5ʹʹ(α-orientated), for H-5ʹʹʹ to H-3ʹʹʹ (β-orientated), and for H-1ʹʹʹʹ to H-3ʹʹʹʹ and H-5ʹʹʹʹ(α-orientated) suggested the relative stereochemistry (Figure 2). Therefore, compound 2 was determined to be glaucogenin A 3-O-β-D-glucopyranosyl-(1→4)-L-diginopyranosyl-(1→4)-β-D-digitoxopyranosyl-(1→4)-β-D-cymaropyranoside, and named cynataihoside J.
Cynataihoside K (3) was isolated as light yellow amorphous gum. Its molecular formula was determined to be C47H72O20 by HR-ESI-MS (m/z 979.4515 [M + Na]+, calcd for 979.4515). From its 1H and 13C NMR spectrum, 3 possessed the similar structure to 2 except for the replacement of the inner sugar. Comparison of 1H and 13C NMR data of 3 with cynataihoside H [13] showed that 3 had the same aglycone and the first inner sugar as those in cynataihoside H: glaucogenin A and oleandrose. Meanwhile, 13C NMR data of β-D-digitoxopyranosyl connected with β-D-oleandropyranosyl in cynamooreoside O [16] were essentially in agreement with those of the corresponding part of 3, indicating that β-D-oleandropyranosyl was a segment of the sugar chain. By detailed analyses of its 2D (HSQC, HMBC and NOESY) spectra, the structure of 3 was further confirmed. On acid hydrolysis, 3 yielded four corresponding sugars. Thus, the above-mentioned evidences determined the structure of 3 as glaucogenin A 3-O-β-D-glucopyranosyl-(1→4)-L-diginopyranosyl-(1→4)-β-D-digitoxopyranosyl-(1→4)-β-D-oleandropyranoside, and named cynataihoside K.
Cynataihoside L (4) was obtained as light yellow amorphous gum. The molecular formula was established as C47H72O20 based on the quasi-molecular ion peak at m/z 979.4507 (calcd, 979.4515) for [M + Na]+ ion observed in its HR-ESI-MS spectrum. The 1H NMR of 4 showed the presence of two tertiary methyl groups (δH 0.83 (3H, s, H-19) and 1.54 (3H, s, H-21)), one olefinic proton (δH 5.39 (1H, m, H-6)), one olefinic deshielded proton (δH 6.47 (1H, s, H-18)) connected with the trisubstituted double bond, and two oxygen-substituted methine protons (δH 3.74 (1H, overlapped with other signals, H-3) and 5.43 (1H, m, H-16)). The data and corresponding 13C NMR (Table 1) were basically consistent with those of glaucogenin C, a known steroidal aglycone, in cynataihoside E [12] and cynatratoside E [7]. The 1H NMR spectrum of 4 showed four anomeric proton signals at (δH 4.79 (1H, br d, J = 9.6 Hz), 5.51 (1H, br d, J = 9.6 Hz), 5.12 (1H, d, J = 7.9 Hz), and 4.74 (1H, d, J = 7.8 Hz)), indicating the existence of four β-linked sugars. The 1H and 13C NMR signals were assigned with the help of an extensive study of HMQC, HMBC, and NOESY experiments. The existence of β-D-oleandropyranosyl, β-D-digitoxopyranosyl, β-D-thevetopyranosyl, and β-D-glucopyranosyl units was confirmed by a further comparison of the sugar chain spectroscopic data of 4 with those of β-D-oleandropyranosyl, β-D-digitoxopyranosyl, and β-D-glucopyranosyl in cynataihoside E [12] and cynatratoside E [7], β-D-glucopyranosyl-(1→4)-β-D-thevetopyranosyl in hoodigoside E [17], and β-D-digitoxopyranosyl in stauntoside L [18]. HMBC correlations further consolidated the sugar sequence: H-1′-Ole (δH 4.79) with C-3 (δC 77.3), H-1′′-Dgt (δH 5.51) with C-4′-Ole (δC 82.9), H-1′′′-The (δH 4.74) with C-4′′-Dgt (δC 83.3), and H-1′′′′-Glc (δH 5.12) with C-4′′′-The (δC 82.6). In the NOESY spectrum, correlations of H-19 to H-8 (β-orientated), of H-17 to H-21 (α-orientated), of H-1′ to H-3, H-3′, and H-5′ (α-orientated), of H-1′′ to H-5′′ (α-orientated), of H-1′′′ to 3′′′ and 5′′′ (α-orientated), and of H-1′′′′ to H-3′′′′ and 5′′′′ (α-orientated) indicated the orientation of the aglycone and sugars (Figure 2). Thus, compound 4 was elucidated to be glaucogenin C 3-O-β-D-glucopyranosyl-(1→4)-D-thevetopyranosyl-(1→4)-β-D-digitoxopyranosyl-(1→4)-β-D-oleandropyranoside, and named cynataihoside L.
Cynataihoside M (7) was isolated as white amorphous gum. The [M + Na]+ ion in HR-ESI-MS (m/z 527.2572, calcd, 527.2621) indicated that the molecular formula of 7 was C28H40O8. The 1H NMR spectrum of 7 showed two tertiary methyl singlets at δH 0.84 (3H, s, H-19) and 1.56 (3H, s, H-21), two oxygen-substituted methine protons at δH 4.25 (1H, br d, J = 10.5 Hz, H-15a), 3.78 (1H, dd, J = 10.5, 4.3 Hz, H-15b), 4.07 (1H, d, J = 8.7 Hz, H-18a), and 4.01 (1H, d, J = 8.7 Hz, H-18b), and one olefinic proton at δH 5.45 (1H, m, H-6). In the 13C NMR spectrum, four olefinic carbons at δc 140.1 (C-5), 120.2 (C-6), 103.4 (C-8), and 152.8 (C-14) were observed. The NMR data were basically consistent with those of a known steroidal aglycone 2α-hydroxyanhydrohirundigenin in sublanceoside E4 [15]. Thus, the glycoside consisted of 2α-hydroxyanhydrohirundigenin with a sugar chain linked at its C-3 hydroxyl group. The proton signals attributed to one secondary methyl and one methoxyl methyl group of deoxysugar, and one anomeric proton signal at δH 4.83 (1H, dd, J = 9.7, 1.5 Hz) indicated that 7 had one deoxysugar with β-linkages. The data and its corresponding 13C NMR data was identical to that of β-D-oleandropyranosyl in glaucoside-A [14]. Acid hydrolysis yielded oleandrose. All the 1H NMR and 13C NMR resonance signals were assigned using HSQC and HMBC spectra. HMBC correlation from δH 4.83 (H-1′) to δC 84.3 (C-3) further revealed the connection site to the aglycone moiety. Relative configuration of 7 was supported by the correlations: H-19/H-2 (β-orientated); H-17/H-16 and H-21 (α-orientated); H-1′/H-3 and H-5′, and H-5′/ H-3′ (α-orientated) (Figure 3). Consequently, the structure of 7 was established as 2α-hydroxyanhydrohirundigenin 3-O-β-D-oleandropyranoside, and named cynataihoside M.
Cynataihoside N (8) was isolated as white amorphous gum, with a molecular formula of C35H52O11, which was determined by HR-ESI-MS (m/z 671.3423 [M + Na]+, calcd for 671.3407). The 1H and 13C NMR spectra of 8 presented similar spectral features to those of 7. From the spectral data similarities, they shared the same aglycone structure and one of the sugars linked at its C-3 hydroxyl group. The anomeric proton resonances at δH 4.78 (1H, br d, J = 8.6 Hz, H-1′) and 5.23 (1H, br d, J = 8.7 Hz, H-1′′) implied the existence of two β-form sugars. The 13C NMR data of the sugar units were basically in accordance with those of β-D-oleandropyranosyl in cynataihoside H [13] and the methyl β-D-cymaropyranoside [7]. Acid hydrolysis of 8 gained oleandrose and cymarose. In HMBC spectrum, the key correlations (Figure 3) between 4.78 (H-1′) and δC 84.1 (C-3), 5.23 (H-1′′) and δC 82.4 (C-4′) suggested the sequence of the sugar chain at C-3. The NOE correlations (Figure 3) from δH 0.83 (H-19) to 2.45 (H-4b) (β-orientated), from δH 2.45 (H-4b) to 3.98 (H-2) (β-orientated), from δH 3.67 (H-3) to 1.41 (H-1b) (α-orientated), from δH 2.20 (H-1a) to 0.83 (H-19) (β-orientated), from H-17 to H-21 (α-orientated), from H-1′ to H-3 and H-5′ (α-orientated), and from H-1′′ to H-5′′ (α-orientated) revealed the orientations. Thus, compound 8 was characterized as 2α-hydroxyanhydrohirundigenin 3-O-β-D-cymaropyranosyl-(1→4)-β-D-oleandropyranoside, and named cynataihoside N.
Cynataihoside O (9) was purified as white amorphous powder, [α ] D 20 −65.00° (c 0.20, MeOH). Its molecular formula was established to be C35H52O11 on the basis of HR-ESI-MS at m/z 671.3374 [M + Na]+ (calcd for 671.3407). The 1H NMR spectrum of 9 showed the signals corresponding to tertiary methyl groups (δH 0.81 (3H, s, H-19) and 1.56 (3H, s, H-21)) and an olefinic proton (δH 5.37 (1H, m, H-6)). In 13C NMR spectrum, 21 carbon signals were ascribed to the aglycone with a seco-pregnane skeleton. The 1H and 13C NMR data (Table 2) of the aglycone part of 9 were basically in consistency with those of 7. Thus, the glycoside was also composed of 2α-hydroxyanhydrohirundigenin with a sugar chain linked at its C-3 hydroxyl group. For the sugar moiety, two secondary methyl signals (δH 1.34 (3H, d, J = 6.1 Hz, H-6′) and δH 1.52 (3H, d, J = 6.1 Hz, H-6′′)), two methoxyl methyl signals (δH 3.57 (3H, s, H-3′-OMe) and δH 3.45 (3H, s, H-3′′-OMe)), and two anomeric protons signals (δH 5.18 (1H, br d, J = 9.5 Hz, H-1′) and 5.05 (1H, br d, J = 9.6 Hz, H-1′′)) in the 1H NMR spectrum revealed that 9 had two β-form deoxysugars units. Comparing the 13C NMR data with those of the first cymarose in sublanceoside G4 [15] and the methyl β-D-cymaropyranoside [7] deduced that compound 9 contained two β-D-cymaropyranosyl groups. Acid hydrolysis yielded D-cymarose. The HMBC correlation from δH 5.18 (H-1′) to δc 84.4 (C-3), and from δH 5.05 (H-1′′) to δc 82.6 (C-4′) indicate the connectivity of the sugars and aglycone. The relative stereochemistry of 9 was elucidated by the NOESY spectrum: correlations for H-19 to H-2 (β-orientated), for H-17 to H-21 (α-orientated), for H-1ʹ to H-5ʹ (α-orientated), and for H-1ʹʹ to H-5ʹʹ(α-orientated). Therefore, the structure of 9 was determined to be 2α-hydroxyanhydrohirundigenin 3-O-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, and named cynataihoside O.
Cynataihoside P (10) was obtained as white amorphous powder, with a molecular formula of C35H50O11 by the [M + Na]+ ion peak at m/z 669.3246 [M + Na]+ (calcd for C35H50NaO11 669.3251) in HR-ESI-MS. The 1H NMR data revealed the presence of tertiary methyl groups (δH 0.77 (3H, s, H-19) and δH 1.56 (3H, s, H-21)), one oxygen-substituted methine proton (4.75 (1H, dd, J = 12.7, 7.0 Hz, H-3)), four oxygen-substituted methylene protons (4.25 (1H, d, 11.0 Hz, H-15a), 3.78 (1H, dd, J = 11.0, 4.3 Hz, H-15b), 4.04 (1H, br d, J = 8.7 Hz, H-18a), and 3.98 (1H, d, J = 8.7 Hz, H-18b)), and one olefinic proton (δH 5.44 (1H, m, H-6)). In combination with analysis of the HMQC and HMBC spectra, the 1H NMR and corresponding 13C NMR spectral data (Table 2) of the aglycone moiety of 10 were similar to 2α-hydroxyanhydrohirundigenin in 9 except the data due to the A ring and B ring. In the 13C NMR spectrum, a characteristic carbon signal at δC 205.7 inferred that the carbon C-2 was carbonylated, which was confirmed by the HMBC correlations from δH 4.75 (H-3), 2.95 (H-4a), 2.37 (H-1a), and 2.33 (H-1b) to δC 205.7, as well as from δH 0.77 (H-19) to δc 137.6 (C-5), 51.5 (C-1), and 44.5 (C-9). Furthermore, correlations between δH 2.34 (H-9) and δC 102.5 (C-8), 153.4 (C-14) established the connectivity between the rings B and C. In addition, the connection of the three furan rings and their connection to the C ring were demonstrated by HMBC correlations of δH 1.56 (H-21) to δC 118.0 (C-20) and 63.3 (C-17), of δH 4.25 (H-15a) to δC 84.3 (C-16), 63.3 (C-17), and 118.0 (C-20), of δH 3.98 (H-18b) to δC 53.6 (C-13), 63.3 (C-17), and 118.0 (C-20), and of δH 4.04 (H-18a) to δC 31.4 (C-12) and 153.4 (C-14). The α-orientation of H-3 was suggested by the large coupling constant between H-3 (δH 4.75 (1H, dd, J = 12.4, 7.0 Hz)) and H-4 (δH 2.95 (1H, dd, J = 14.2, 7.0 Hz, H-4a) and 2.63 (1H, m, H-4b)), as well as the NOE correlations for H-3/H-1b (δH 2.33) and H-4a (α-orientated), and for H-19/H-4b (β-orientated). In addition, the NOE correlations for H-17/Me-21 indicated their α-orientation (Figure 3). Thus, the aglycone structure was determined to be 2-carbonylanhydrohirundigenin. It was a new seco-pregnane-type steroidal aglycone, and named cynataihogenin P. The sugar chain was linked to its C-3 hydroxyl group. The 1H NMR displayed two secondary methyl and two methoxyl methyl signals of deoxysugars and two anomeric proton signals at δH 5.28 (1H, dd, J = 9.4, 1.7 Hz, H-1′) and 5.06 (1H, dd, J = 9.7, 1.6 Hz, H-1′′), which implied the presence of two deoxysugar units with β-linkages. The NMR data of sugar moiety were basically consistent with those of 9 except the proton signals due to the anomeric atom connected with the aglycone, which were identical to the data of β-D-cymarose linked with the aglycone of cynataihoside F [12]. Hydrolysis of 10 gave D-cymarose. Thus, compound 10 possessed the same sugar chain as that of 9. The attachments of the sugars and aglycone were determined by HMBC (Figure 3). The NOE spectrum further suggested the relative stereochemistry of the sugar moiety of 10: correlations for H-1ʹ to H-5ʹ (α-orientated), and for H-1ʹʹ to H-5ʹʹ(α-orientated) (Figure 3). Thus, the structure of 10 was established as cynataihogenin P 3-O-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, and named cynataihoside P.
Cynataihoside Q (11) was white amorphous powder and its positive HR-ESI-MS gave a quasi-molecular ion peak at m/z 655.3096 (calcd, 655.3094) for [M + Na]+ ion, based on which the molecular formula was calculated as C34H48O11. A detailed comparison between the 1H and 13C NMR data of 11 and those of 10 in Table 2 indicated they had the same aglycone and one β-D-cymaropyranosyl connected with their C-3 hydroxyl group, but different terminal sugar. From the 13C NMR spectra, the outer deoxysugar units were in good agreement with the terminal β-D-digitoxopyranosyl in sublanceoside B2 [15]. The HMBC spectrum showed correlations from δH 5.35 (1H, br d, J = 9.6 Hz, H-1′′) to δc 82.7 (C-4′), and from δH 4.75 (H-3) to δc 95.5 (C-1′), which further confirmed the linkage sugar sequence. On acid hydrolysis of 11, cymarose and digitoxose were afforded. Thus, all the above-mentioned evidences with the NOESY spectrum in Figure 3 confirmed 11 as cynataihogenin P 3-O-β-D-cymaropyranosyl-(1→4)-β-D-digitoxopyranoside, and named cynataihoside Q.
Cynataihoside R (12) was afforded as white amorphous powder. Its molecular formula was determined to be C34H50O11 by HR-ESI-MS at m/z 657.3229 [M + Na]+ (calcd for 657.3251). From its 13C NMR data (Table 2), it was apparent that 12 consisted of the same aglycone as that of 9. Two anomeric proton signals at δH 5.18 (1H, br d, J = 9.6 Hz, H-1′) and 5.34 (1H, br d, J = 9.6 Hz, H-1′′) and their corresponding anomeric carbon signals at δc 97.4 and 100.5, respectively, revealed that 12 had two sugars with β-linkages. Its NMR data of sugar moiety were a close resemblance to those of 11 except for a small increase of chemical shifts at C-1′ and C-2′ of β-D-cymaropyranosyl. Considering that the change in chemical shifts was probably caused by different aglycones linked to sugars, it was speculated that they had the same sugar units. Cymaroses and digitoxose were afforded in the acid hydrolysis experiment. In addition, the existence of β-D-cymaropyranosyl was further confirmed by comparison with the corresponding spectroscopic data of 9. The linkage positions and sequence of the two sugars were ascertained by HMBC correlations from δH 5.34 (1H, br d, J = 9.6 Hz, H-1′′ of β-digitoxopyranose) to δc 82.7 (C-4′) and from δH 5.18 (1H, br d, J = 9.6 Hz, H-1′ of β-cymaropyranose) to δc 84.5 (C-3) (Figure 3). The NOE spectrum further suggested the relative stereochemistry of 12. Thus, the structure of 12 was elucidated as 2α-hydroxyanhydrohirundigenin 3-O-β-D-cymaropyranosyl-(1→4)-β-D-digitoxopyranoside, and named cynataihoside R.
Cynataihoside S (13) was isolated as white amorphous powder. HR-ESI-MS of 13 showed a [M + Na]+ ion peak at m/z 975.46006 (calcd, 975.456001) that accounted for a molecular formula of C48H72O19. Inspection of the NMR data of 13 in Table 2 revealed the same aglycone as that of 10. The large coupling constant between H-3 (δH 4.74 (1H, dd, J = 12.4, 7.0 Hz)) and H-4 (δH 2.93 (1H, dd, J = 14.2, 7.0 Hz, H-4a) and 2.62 (1H, m, H-4b)), as well as the NOE correlation for H-3/H-1b (δH 2.33) and H-4a (α-orientated), and for H-19/H-4b (β-orientated) confirmed the α-orientation of H-3. Thus, 13 was composed of cynataihogenin P and a sugar chain with linked C-3 group. The 1H NMR spectrum of 13 showed three secondary methyl and three methoxyl methyl signals of deoxysugars and four anomeric proton signals at δH 5.26 (1H, dd, J = 9.6, 1.6 Hz, H-1′), 5.05 (1H, br d, J = 9.4 Hz, H-1′′), 4.93 (1H, br d, J = 2.5 Hz, H-1′′′), and 4.99 (1H, d, J = 7.8 Hz), which revealed the existence of four sugars with three β- and one α- form. According to the comparison of its 13C NMR data to those in cynataihoside F [12], the sugar chain was proposed to be glucopyranosyl-(1→4)-α-L-cymaropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranosyl. This was further supported by hydrolysis experiment and 2D NMR (Figure 3). Acidic hydrolysis of 13 produced cymarose and glucose. The absolute configurations of sugars were determined by HPLC analysis and the comparison of their spectral data with those that possessed the same sugar chain unit reported in the literature [15]. The connection and the sequence of the sugar chain were further established by HMBC correlations between δH 4.99 (glc-H-1′′′′) and δC 78.7 (α-cym-C-4′′′), δH 4.93 (α-cym-H-1′′′) and δC 82.0 (β-cym-C-4′′), δH 5.05 (β-cym-H-1′′) and δC 82.6 (β-cym-C-4′), and δH 5.26 (β-cym-H-1′) and δC 77.9 (C-3). Therefore, the structure of 13 was identified as cynataihogenin P 3-O-β-D-glucopyranosyl-(1→4)-α-L-cymaropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, and designated cynataihoside S.
Cynataihoside T (14) was obtained as white amorphous powder, and possessed the same molecular formula as 13 according to HR-ESI-MS data (m/z 975.45963 [M + Na]+, calculated for C48H72NaO19, 975.456001). The 1H and 13C NMR signals assignable to 14 unambiguously by HSQC and HMBC analyses were extremely similar to 13. The data (Table 2) revealed that they had basically consistent sugar units, but differed a little bit in the aglycone moiety. The 1H NMR signal due to H-3 of 14 was observed at δH 4.50 (1H, t, J = 3.5 Hz) instead of δH 4.74 (1H, dd, J = 12.4, 7.0 Hz, H-3 of 13), indicating the β-orientation of H-3 in 14. The absence of the NOESY correlations of δH 4.50 (H-3) to δH 2.82 (H-4a) and of δH 2.82 (H-4a) to δH 0.80 (H-19) also supported the β-orientation of H-3. In addition, other signals by detailed 1D NMR and 2D NMR spectral analysis were also assigned to elucidate the structure (Figure 3). Therefore, the aglycone of 14 was determined as 3-epi-cynataihogenin P, also a new compound, named cynataihogenin T. Acid hydrolysis of 14 yielded cymarose and glucose. Hence, together with the 2D NMR (Figure 3) analyses, the structure of compound 14 was elucidated to be cynataihogenin T 3-O-β-D-glucopyranosyl-(1→4)-α-L-cymaropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, and designated cynataihoside T.
The known compounds were identified as glaucoside A [14] (5) and atratcynoside F [6] (6) by comparing their 1H and 13C NMR data to those in the literature.

2.2. Cytotoxic Activities

The cytotoxic activities of compounds 114 against HL-60 (human leukemic promyelocytic cell), THP-1 (human acute monocytic leukemia cell line) and compounds 1, 3, 1014 against PC-3 (prostate cancer cell line) were evaluated. The cytotoxicity data represented by IC50 values in μm are shown in Table 3, in which 5-Fluorouracil was used as a positive control and their IC50 values against HL-60, THP-1, and PC-3 were 9.93, 5.82, and 22.15 μm, respectively. As evident from results, the compounds exhibited varying degrees of cytotoxic activity. Compound 11 was more active than others, especially on THP-1 and PC-3, and showed significant cytotoxicity similar to the positive control. Compounds 3 and 14 moderately and selectively inhibited the proliferation of HL-60 and THP-1 with IC50 values of 17.78 and 16.02 μm, respectively.

3. Materials and Methods

3.1. General Experiment Procedure

Optical rotations were measured on a WZZ-2A (Shanghai base solid Instrument Co., Ltd., Shanghai, China). The IR spectra were obtained from a Bruker IFS-55 spectrophotometer (Karlsruhe, Germany) with KBr disks. HR-ESI-MS data were measured on a Micro-mass Autospec-UntimaE TOF mass spectrophotometer (Waters, Milford, MA, USA) and a Bruker Solarix 7.0T FT-ICR MS system (Bruker, Germany). NMR spectra were run on a Bruker AVANCE-400/-600 spectrometer (Karlsruhe, Germany). Analytical HPLC was performed on a Shimadzu LC-10AT (Kyoto, Japan) liquid chromatograph and preparative HPLC separation was carried out on a YMC-Pack ODS-A column (10 × 250 mm, 5 μm; YMC-Pack, Kyoto, Japan), equipped with a Shimadzu LC-8A pump (Kyoto, Japan) and a Shimadzu SPD-10A UV–V is detector (Kyoto, Japan). Sugars analytical HPLC was carried out on a Jasco PU-4180 pump (Kyoto, Japan) and an OR-4090 detector (Kyoto, Japan).

3.2. Plant Material

The fresh whole plants (4.7 kg) of C. taihangense were collected in August 2014 at Wangmang Ridge in Shanxi Province, China. A voucher specimen was identified by Prof. Jing-Ming Jia of Shenyang Pharmaceutical University and was deposited in the School of Traditional Chinese Materia Medica of Shenyang Pharmaceutical University (NO. SYPC201408316).

3.3. Cell Lines

The human leukemic promyelocytic cell (HL-60), human acute monocytic leukemia cell line (THP-1), and prostate cancer cell line (PC-3) were provided by America Type Culture Collection, ATCC (Rockville, MD, USA).

3.4. Extraction and Isolation

The fresh whole plants (4.7 kg) of C. taihangense were extracted with 95% EtOH, and water suspension of the extraction was then partitioned with petroleum ether, ethyl acetate, and n-butanol, successively [11].
The ethyl acetate extract (110 g) was further pre-fractioned by a gel column to give thirteen fractions (Fr. 1–13). Fr. 6 was separated by the same procedures as those in our previous report [11] to afford nine fractions (Fr. 6-5-4-4-1–Fr. 6-5-4-4-9). Fr. 6-5-4-4-4 was purified via Sephadex LH-20 eluting with MeOH, and then isolated by semi-preparative HPLC eluting with CH3OH/H2O (67:33 v/v, flowrate 2.5 mL/min) to yield compound 1 (20 mg). Fr. 8 was separated into five fractions (Fr. 8-1–Fr. 8-5) by a C18 column using gradients of MeOH/H2O (20:80) to (100:0) as the eluent. Fr. 8-4 was further submitted to a silica gel column with CH2Cl2/MeOH (100:0 to 0:100 v/v) to obtain sub-fractions. Fr. 8-4-5 and Fr. 8-4-6 were sent to a reversed-phase preparative HPLC in CH3CN/H2O (45:55 v/v, flowrate 4 mL/min), respectively. Compound 4 (7 mg) was obtained from Fr. 8-4-6. Compound 3 (18 mg) was obtained from Fr. 8-4-5. Fr. 8-4-5-4 was further purified by preparative TLC to give compound 2 (7 mg).
The n-butanol extract (150 g) was further fractionated by D101 macroporous adsorptive resins column chromatography eluting with MeOH/H2O (0:100–100:0, v/v) to obtain six fractions (Fr. 1–6). Fr. 6 was separated into fifteen fractions (Fr. 6-1–Fr. 6-15) by silica gel column using CH2Cl2/MeOH (100:0–0:100, v/v) as the eluent. Fr. 6-2, Fr. 6-3, Fr. 6-4, Fr. 6-7, and Fr. 6-8 were further subjected to semi-preparative HPLC with the elution of MeOH/H2O (57:43 v/v, flowrate 2.5 mL/min) and CH3CN/H2O (48:52 v/v, 48:52 v/v, 48:52 v/v, flowrate 4 mL/min, and 42:58 v/v, flowrate 3 mL/min), respectively. Compound 6 (9 mg, tR 36 min) and compound 8 (10 mg, tR 43 min) were separately obtained from Fr. 6-2 and Fr. 6-4. Compounds 5 (9 mg, tR 29 min), 9 (11 mg, tR 53 min), and 10 (45 mg, tR 32 min) were recrystallized from Fr. 6-3. Compound 11 (5 mg, tR 19 min) and 12 (9 mg, tR 28 min) were obtained from Fr. 6-7. Compound 13 (60 mg, tR 110 min) and 14 (24 mg, tR 140 min) were afforded from Fr. 6-8.
Cynataihoside I (1): Light yellow amorphous gum (MeOH), [α ] D 20 −33.18° (c 0.75, MeOH); IR (KBr) νmax cm−1: 3440, 2970, 2934, 2170, 1737, 1653, 1632, 1450, 1384, 1311, 1273, 1165, 1083, 1023, 914, 864; for 1H NMR and 13C NMR (C5D5N) data see Table 1; HR-ESI-MS m/z: 993.4678 [M + Na]+ (calcd for C48H74NaO20, 993.4671).
Cynataihoside J (2): Light yellow amorphous gum (MeOH), [α ] D 20 −245.00° (c 0.10, MeOH); IR (KBr) νmax cm−1: 3429, 2933, 2170, 1736, 1631, 1384, 1311, 1272, 1165, 1081, 1021, 914, 865, 832; for 1H NMR and 13C NMR (C5D5N) data see Table 1; HR-ESI-MS m/z: 979.4509 [M + Na]+ (calcd for C47H72NaO20 979.4515).
Cynataihoside K (3): Light yellow amorphous gum (MeOH), [α ] D 20 −37.98° (c 1.47, MeOH); IR (KBr) νmax cm−1: 3436, 2933, 2170, 1736, 1631, 1384, 1310, 1272, 1164, 1102, 1079, 1020, 903, 876, 833, 809; for 1H NMR and 13C NMR (C5D5N) data see Table 1 HR-ESI-MS m/z: 979.4515 [M + Na]+ (calcd for C47H72NaO20, 979.4515).
Cynataihoside L (4): Light yellow amorphous gum (MeOH), [α ] D 20 9.00° (c 0.20, MeOH); IR (KBr) νmax cm−1: 3423, 2933, 2170, 1736, 1653, 1631, 1406, 1384, 1310, 1272, 1164, 1080, 913, 872, 832; for 1H NMR and 13C NMR (C5D5N) data see Table 1; HR-ESI-MS m/z: 979.4507 [M + Na]+ (calcd for C47H72NaO20, 979.4515).
Cynataihoside M (7): White amorphous gum (MeOH), [α ] D 20 −80.33° (c 0.10, MeOH); IR (KBr) νmax cm−1: 3429, 2934, 2170, 1631, 1407, 1384, 1272, 1166, 1103, 1066, 987, 896, 833; for 1H NMR and 13C NMR (C5D5N) data see Table 1; HR-ESI-MS m/z: 527.2572 [M + Na]+ (calcd for C28H40NaO8, 527.2621).
Cynataihoside N (8): White amorphous gum (MeOH), [α ] D 20 −105.50° (c 0.20, MeOH); IR (KBr) νmax cm−1: 3439, 2934, 2659, 2170, 1631, 1406, 1384, 1272, 1163, 1062, 1007, 916, 833; for 1H NMR and 13C NMR (C5D5N) data see Table 1; HR-ESI-MS m/z: 671.3423 [M + Na]+ (calcd for C35H52NaO11, 671.3407).
Cynataihoside O (9): White amorphous powder, [α ] D 20 −65.00° (c 0.20, MeOH); for 1H NMR and 13C NMR (C5D5N) data see Table 2; HR-ESI-MS m/z: 671.3374 [M + Na]+ (calcd for C35H52NaO11, 671.3407).
Cynataihoside P (10): White amorphous powder, [α ] D 20 −51.13° (c 0.40, MeOH); IR (KBr) νmax cm−1: 3420, 2967, 2933, 2170, 1735, 1631, 1407, 1384, 1273, 1192, 1163, 1146, 1089, 1066, 1004, 920, 900, 868, 832; for 1H NMR and 13C NMR (C5D5N) data see Table 2; HR-ESI-MS m/z: 669.3246 [M + Na]+ (calcd for C35H50Na O11, 669.3251).
Cynataihoside Q (11): White amorphous powder, [α ] D 20 −251.00° (c 0.10, MeOH); IR (KBr) νmax cm−1: 3430, 2932, 2170, 1726, 1632, 1406, 1384, 1388, 1271, 1165, 1064, 1009, 867, 833; for 1H NMR and 13C NMR (C5D5N) data see Table 2; HR-ESI-MS m/z: 655.3096 [M + Na]+ (calcd for C34H48NaO11, 655.3094).
Cynataihoside R (12): White amorphous powder, [α ] D 20 −120.17° (c 0.20, MeOH); IR (KBr) νmax cm−1: 3430, 2933, 2659, 2170, 1631, 1405, 1384, 1319, 1271, 1165, 1161, 1010, 916, 867, 833; for 1H NMR and 13C NMR (C5D5N) data see Table 2; HR-ESI-MS m/z: 657.3229 [M + Na]+ (calcd for C34H50NaO11, 657.3251).
Cynataihoside S (13): White amorphous powder, [α ] D 20 −193.53° (c 0.17, MeOH); IR (KBr) νmax cm−1: 3444, 2971, 2934, 1728, 1632, 1451, 1383, 1319, 1195, 1061, 1004, 896, 867, 835; for 1H NMR and 13C NMR (C5D5N) data see Table 2; HR-ESI-MS m/z: 975.46006 [M + Na]+ (calcd for C48H72NaO19, 975.456001).
Cynataihoside T (14): White amorphous powder, [α ] D 20 −57.92° (c 0.53, MeOH); IR (KBr) νmax cm−1: 3439, 2970, 2933, 2170, 1722, 1632, 1384, 1319, 1273, 1195, 1165, 1061, 1006, 896, 868, 834; for 1H NMR and 13C NMR (C5D5N) data see Table 2; HR-ESI-MS m/z: 975.45963 [M + Na]+ (calcd for C48H72NaO19, 975.456001).

3.5. Acid Hydrolysis of Compounds 14, 78, and 914

Acid hydrolysis was prepared by following the methods described in our previous report [11,12,13]. Each solution of 7 (15 mg), 8, 9, 11, 12 (2 mg), and 10 (30 mg), in MeOH (1 mL for 8, 9, 11, and 12, and 3 mL for 7 and 10) were heated separately with 0.1 N H2SO4 (1 mL for 8, 9, 11, and 12, and 3 mL for 7 and 10) at 50 °C for 30 min. Then the mixture was diluted with water (2 mL for 8, 9, 11, and 12, and 6 mL for 7 and 10) and concentrated to (2 mL for 8, 9, 11, and 12, and 6 mL for 7 and 10). After that, the solution was kept at 60 °C for a further 30 min, followed by neutralizing with aqueous saturated Ba(OH)2, and the precipitates were filtered off.
Each solution of 1 (5 mg), 2 (2 mg), 3 (5 mg), 4 (2 mg), 13 (18 mg), and 14 (18 mg) in 50% 1,4-dioxane (4 mL, 2 mL, 4 mL, 2 mL, 10 mL, and 10 mL) was heated separately with 0.5 N H2SO4 (4 mL, 2 mL, 4 mL, 2 mL, 10 mL, and 10 mL) at 95 °C for 3 h. Reaction mixture was cooled, neutralized with aqueous saturated Ba(OH)2, and the precipitates were filtered off [17].
The filtrate was partitioned between CH2Cl2 and H2O. The aqueous layer was concentrated and further analyzed by TLC. The known steroidal glycosides were hydrolyzed to give deoxysugars to make a comparison. Three solvent systems, CHCl3/CH3OH (9:1 v/v), CH2Cl2/C2H5OH (9:1 v/v), and PE/acetone (3:2 v/v), were performed to reference the Rf values of oleandrose, digitoxose, cymarose, and diginose according to the literature [8]. In the hydrolysate of 13 and 714, the corresponding deoxysugars Rf values were basically identical to the corresponding ones mentioned in the reports.

3.6. Determination of Absolute Configuration of Sugars

The configurations of the monosaccharides were identified by the comparison of their spectral data with those in the literature and HPLC analysis.
The concentrated aqueous layer of 14, 8, and 914 (24 h after dissolution) were subjected to HPLC analysis under the following conditions: column, Shodex Asahipak NH2P-50 4E column (4.6 mm × 250 mm, 5 μm); flowrate, 0.8 mL/min; solvent, MeCN/H2O (3:1 v/v); detection, OR (Jasco OR-4090) detector. D-glucose (tR 10.8 min, positive polarity) in compounds 14, 13, and 14, D-digitoxose in compounds 13, 11, and 12, L-diginose in compounds 13, and D-cymarose in 12 and 814 were identified.
Since the impurities produced during the hydrolysis process interfered with the detection, the absolute configuration of oleandrose in compounds 3, 4, 7, and 8 was determined to be D-form by the spectroscopic data. Those oleandroses were all directly linked to their respective aglycones so that the absolute configurations could be suggested by the NMR data.
Unfortunately, owing to the failure of hydrolysis of compound 4, as well as the deficiency of authentic samples of thevetose, the monosaccharides of 4 were not detected completely. The configurations of the deoxysugars were further identified by the comparison of those spectral data with those in the literature.

3.7. Cytotoxicity Assay

An MTT assay was used to determine the cytotoxicity effect of the compounds on three cultured human cancer cell lines, including HL-60 (human leukemic promyelocytic cell), THP-1 (human acute monocytic leukemia cell line), and PC-3 (prostate cancer cell line). Cell growth inhibition assay was performed as reported previously [19]. 5-Fluorouracil was used as a positive control.

4. Conclusions

Fourteen seco-pregnane steroidal glycosides, including twelve new ones (14 and 714), were isolated from the ethanolic extract of C. taihangense by multiple separation methods. All compounds were reported for the first time from the plant. Among them, compounds 10, 11, 13, and 14 contained two new seco-pregnane-type aglycones. In addition, the cytotoxicity of the glycosides against HL-60, THP-1, and PC-3 cell lines were evaluated. Compound 11 displayed significant cytotoxicity against THP-1 and PC-3 cell line. Compounds 3 and 14 exhibited moderate and selective cytotoxic activity on HL-60 and THP-1.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules27175500/s1. Figures S1–S84: IR, HR-ESI-MS, 1D, and 2D NMR spectra of compounds 14, 714; Figures S85–S88: 1D NMR spectra of compounds 5 and 6.

Author Contributions

Y.-B.W. designed the experiments, conducted the isolation and structural determination, and wrote the manuscript. D.Z. contributed to the biological activity evaluation. S.-S.S. performed acid hydrolysis of compounds and revised the manuscript. G.C. and H.-F.W. contributed to validation and review. Y.-H.P. conceived the experiments. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Science Fund for Young Scholars of The Educational Department of Liaoning Province of China (NO. JYTQN201922), and Liaoning Provincial Key Laboratory of Marine Bioactive Substances and Technological Innovation Center of Liaoning Pharmaceutical Action and Quality Evaluation (NO. 2020-01; NO. 2021-7).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in this article.

Acknowledgments

We thank Jing-Ming Jia and San-Peng Fan (School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University) for the identification and collection of the plant.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Lin, Y.L.; Lin, T.C.; Kuo, Y.H. Five new pregnane glycosides from Cynanchum taiwanianum. J. Nat. Prod. 1995, 58, 1167–1173. [Google Scholar] [CrossRef] [PubMed]
  2. Warashina, T.; Noro, T. Steroidal glycosides from roots of Cynanchum caudatum M. II. Chem. Pharm. Bull. 1995, 43, 1734–1737. [Google Scholar] [CrossRef] [PubMed]
  3. Yan, Y.; Zhang, J.X.; Liu, K.X.; Huang, T.; Yan, C.; Huang, L.J.; Liu, S.; Mu, S.Z.; Hao, X.J. Seco-pregnane steroidal glycosides from the roots of Cynanchum atratum and their anti-TMV activity. Fitoterapia 2014, 97, 50–63. [Google Scholar] [CrossRef] [PubMed]
  4. Qiu, S.X.; Li, D.Z.; Zhang, Z.X.; Zhou, J.; Wu, C.Y. Chemotaxonomy of Cynanchum and its allied genera with notes on the generic characteristics of Vincetoxicum. Acta Bot. Yunnanica 1989, 11, 41–50. [Google Scholar]
  5. Yu, J.-Q.; Zhao, L. Seco-pregnane steroidal glycosides from the roots of Cynanchum stauntonii. Phytochem. Lett. 2016, 16, 34–37. [Google Scholar] [CrossRef]
  6. Zhang, Z.J.; Ding, M.L.; Tao, L.J.; Zhang, M.; Xu, X.H.; Zhang, C.F. Immunosuppressive C₂₁ steroidal glycosides from the root of Cynanchum atratum. Fitoterapia 2015, 105, 194–201. [Google Scholar] [CrossRef] [PubMed]
  7. Zhang, Z.X.; Zhou, J.; Hayashi, K.; Mitsuhashi, H. Studies on the constituents of asclepiadaceae plants. LVIII. The structures of five glycosides, cynatratoside-A, -B, -C, -D, and -E, from the Chinese drug “pai-wei”, Cynanchum atratum Bunge. Chem. Pharm. Bull. 1985, 33, 1507–1514. [Google Scholar] [CrossRef] [PubMed]
  8. Chen, H.; Xu, N.; Zhou, Y.; Qiao, L.; Cao, J.; Yao, Y.; Hua, H.; Pei, Y. Steroidal glycosides from the roots of Cynanchum amplexicaule Sieb. et Zucc. Steroids 2008, 73, 629–636. [Google Scholar] [CrossRef] [PubMed]
  9. Tsiang, Y.; Li, P.-T. Praecursores Florae Asclepiadacearum Sinensium. Acta Phytotaxon. Sin. 1974, 12, 102. [Google Scholar]
  10. Li, P.T.; Gilbert, M.G.; Stevens, W.D. Asclepiadaceae. In Flora of China, Flora of China Editorial Committee; Wu, Z.Y., Raven, P.H., Eds.; Science Press: Beijing, China; Missouri Botanical Garden: St. Louis, MO, USA, 1995; Volume 16, pp. 205–223. [Google Scholar]
  11. Wang, Y.-B.; Su, S.-S.; Chen, S.-F.; Tang, M.-X.; Chen, G.; Zhao, D.; Sang, X.-N.; Si, Y.-Y.; Wang, H.-F.; Pei, Y.-H. C-21 steroidal glycosides with cytotoxic activity from Cynanchum taihangense. Phytochem. Lett. 2017, 20, 218–223. [Google Scholar] [CrossRef]
  12. Wang, Y.-B.; Su, S.-S.; Chen, S.-F.; Tang, M.-X.; Chen, G.; Zhao, D.; Sang, X.-N.; Si, Y.-Y.; Wang, H.-F.; Pei, Y.-H. C-21 steroidal glycosides from Cynanchum taihangense. J. Asian Nat. Prod. Res. 2018, 20, 263–269. [Google Scholar] [CrossRef] [PubMed]
  13. Wang, Y.-B.; Su, S.-S.; Tang, M.-X.; Zhao, D.; Chen, G.; Chen, S.-F.; Wang, H.-F.; Pei, Y.-H. Two new pregnane steroidal glycosides from Cynanchum taihangense. Nat. Prod. Res. 2021, 35, 2308–2314. [Google Scholar] [CrossRef] [PubMed]
  14. Nakagawa, T.; Hayashi, K.; Wada, K.; Mitsuhashi, H. Studies on the constituents of asclepiadaceae plants-LII: The structures of five glycosides glaucoside-A, -B, -C. -D. and -E from chinese drug “Pai-ch’ien” Cynanchum glaucescens HAND-MAZZ. Tetrahedron 1983, 39, 607–612. [Google Scholar] [CrossRef]
  15. Warashina, T.; Noro, T. Glycosides of 14,15-seco and 13,14:14,15-disecopregnanes from the roots of Cynanchum sublanceolatum. Chem. Pharm. Bull. 2006, 54, 1551–1560. [Google Scholar] [CrossRef] [PubMed]
  16. Cui, B.; Wang, X.; Yang, Y.; Yang, Y.; Shi, S.; Guo, F.; Li, Y. Sixteen novel C-21 steroidal glycosides from the roots of Cynanchum mooreanum. Steroids 2015, 104, 79–94. [Google Scholar] [CrossRef] [PubMed]
  17. Pawar, R.S.; Shukla, Y.J.; Khan, S.I.; Avula, B.; Khan, I.A. New oxypregnane glycosides from appetite suppressant herbal supplement Hoodia gordonii. Steroids 2007, 72, 524–534. [Google Scholar] [CrossRef] [PubMed]
  18. Yu, J.Q.; Zhang, Z.H.; Deng, A.J.; Qin, H.L. Three new steroidal glycosides from the roots of Cynanchum stauntonii. Biomed. Res. Int. 2013, 2013, 816145. [Google Scholar] [CrossRef] [PubMed]
  19. Sang, X.N.; Chen, S.F.; Chen, G.; An, X.; Li, S.G.; Li, X.N.; Lin, B.; Bai, J.; Wang, H.F.; Pei, Y.H. Phomeketales A–F, six unique metabolites from the endophytic fungus Phoma sp. YN02-P-3. RSC Adv. 2016, 6, 64890–64894. [Google Scholar] [CrossRef]
Figure 1. Structures of compounds 114.
Figure 1. Structures of compounds 114.
Molecules 27 05500 g001
Figure 2. Key HMBC and NOESY correlations of compounds 14.
Figure 2. Key HMBC and NOESY correlations of compounds 14.
Molecules 27 05500 g002
Figure 3. Key HMBC and NOESY correlations of compounds 714.
Figure 3. Key HMBC and NOESY correlations of compounds 714.
Molecules 27 05500 g003
Table 1. 1H and 13C NMR data in C5D5N for compounds 15, 78.
Table 1. 1H and 13C NMR data in C5D5N for compounds 15, 78.
NO.123478
δH bδC dδH bδC eδH bδC dδH bδC dδH cδC eδH cδC e
12.46 a, 1.23 (m)44.52.46 a,1.23 a44.52.46 a, 1.25 a 44.51.81 (m), 0.94 (m)36.22.22 a, 1.42 a44.62.20 a, 1.41 a44.6
24.00 a69.74.00 (m)69.84.00 a69.62.04 a, 1.42 a29.83.99 a69.93.98 (m)69.8
33.58 a85.23.57 a85.23.63 (m)84.73.74 a77.33.70 a84.33.67 (m)84.1
42.48 a, 2.42 a37.32.47 a, 2.41 a37.32.55 a, 2.44 a 37.12.55 a, 2.29 (m)38.82.64 (dd, 14.6, 5.0), 2.50 a37.22.61 (dd, 14.2, 5.0),
2.45 a
37.2
5139.5139.6139.5140.4140.1140.1
65.41 (m)120.55.40 (m)120.55.44 (m)120.65.39 (m)120.25.45 (m)120.25.42 (m)120.3
72.64 (m), 2.14 a28.22.65 (m), 2.14 (m)28.22.65 (m), 2.14 a28.22.64 a, 2.15 (m)28.23.17 (dd, 21.0, 3.8) 2.74 (d, 21.0)25.63.17 (dt, 21.1, 3.9),
2.74 (d, 21.0)
25.6
82.47 a40.02.47 a40.02.49 a40.02.50 a40.4103.4103.5
91.33 a52.81.32 a52.81.32 a52.81.22 (t, 10.3)53.02.20 a44.82.20 a44.9
1039.239.439.338.438.538.5
112.10 a, 1.40 a29.82.09 a, 1.39 a29.82.14 a, 1.41 a29.82.12 a, 1.71 (m)29.71.64 a, 1.29 a20.01.63 a 1.27 a20.0
122.53 (m), 1.33 a23.62.54 a, 1.33 a23.62.55 a, 1.35 a23.62.60 a, 1.38 a23.71.92 (m), 1.41 a31.61.92 (m), 1.41 a31.6
13114.1114.1114.1114.153.553.5
14175.1175.1175.1175.3152.8152.9
154.25 a, 3.94 a67.54.23 a, 3.93 (t)67.64.24 (m), 3.93 (m)67.54.24 a, 3.95 a67.54.25 (br d, 10.5), 3.78 (dd, 10.5, 4.3) 72.14.25 (br d, 10.8),
3.79 (dd, 10.8, 4.3)
72.1
165.43 (m)75.35.43 (m)75.35.43 (m)75.35.44 (m)75.34.76 (dd, 8.0, 4.3)84.14.76 (m)84.2
173.52 a55.93.53 a55.93.53 a55.93.55 a55.92.80 (d, 8.0)63.32.80 (d, 7.9)63.4
186.47 (1H, s)143.66.46 (1H, s)143.66.47 (s)143.66.47 (s)143.64.07 (d, 8.7),
4.01 (d, 8.7)
76.44.07 a,
4.01 (d, 8.7)
76.4
190.89 (3H, s)18.70.88 (3H, s)18.70.90 (3H, s)18.70.83 (3H, s)17.60.84 (3H, s)19.40.83 (3H, s)19.4
20118.3118.3118.3118.3118.0118.0
211.53 (3H, s)24.51.53 (s)24.61.53 (3H, s)24.51.54 (3H, s)24.51.56 (3H, s)22.31.56 (3H, s)22.4
β-D-Cymβ-D-Cymβ-D-Oleβ-D-Oleβ-D-Oleβ-D-Ole
1′5.18 (br d, 9.5)97.65.19 (br d, 9.7)97.64.78 (br d, 9.7)98.74.79 (br d, 9.6)97.94.83 (dd, 9.7, 1.5)98.94.78 (br d, 8.6)98.6
2′2.35 a,1.89 (m)36.72.35 a,1.90 a36.82.44 a, 1.77 (m)37.52.42 a, 1.81 (m)37.82.50 a, 1.75 (m)37.02.44 a, 1.76 a37.4
3′4.04 (m)77.64.10 (m)77.73.56 a78.73.55 a78.93.48 a81.23.55 a78.7
4′3.47 a82.73.47 a82.73.54 a82.43.54 a82.93.48 a75.83.51 a82.4
5′4.23 a69.14.21 a69.23.56 a71.73.53 a71.53.63 a72.83.59 a71.7
6′1.33 (3H, d, 6.2)17.91.29 (3H, d, 6.3)17.91.38 (3H, d, 5.8)18.21.45 (3H, d, 5.3)18.61.53 (3H, d, 6.0)18.21.42 (3H, d, 6.0)18.3
3′-OMe3.59 (3H, s)58.75.19 (br d, 9.7)58.83.54 (3H, s)57.33.53 (3H, s)57.23.45 (3H, s)56.83.52 (3H, s)57.1
β-D-Cymβ-D-Dgtβ-D-Dgtβ-D-Dgt β-D-Cym
1′′5.05 (br d, 9.6)99.95.32 (brd, 9.6)100.35.50 (br d, 9.6)98.25.51 (br d, 9.6)98.35.23 (br d, 8.7)98.3
2′′2.38 a, 1.71 a34.82.40 a, 1.94 a39.32.39 a, 1.94 (m)39.52.42 a, 2.00 a39.02.36 (m), 1.75(m) 35.6
3′′3.88 (m)77.24.54 a67.54.56 a67.64.66 a67.73.75 (m)78.7
4′′3.44 a82.03.50 a82.03.51 a82.03.53 a83.33.52 (m)73.9
5′′4.19 a69.04.34 (m)68.54.36 a68.74.34 (m)68.84.12 (m)71.0
6′′1.33 (3H, d, 6.2)18.31.39 (3H, d, 6.3)18.31.41 (3H, d, 6.2)18.31.59 (3H, d, 6.2)18.31.53 (3H, d, 6.2)18.8
3′′-OMe3.51 (3H, s)57.03.44 (3H, s)57.7
α-L-Dgnα-L-Dgnα-L-Dgnβ-D-The
1′′′5.20 (br s)100.85.27 (brd, 3.0)100.65.27 (br d, 3.1)100.54.74 (d, 7.8)105.4
2′′′2.36 a, 2.05 a31.92.37 a, 2.08 a32.02.34 a, 2.06 a31.93.77 a74.2
3′′′3.88 a74.93.81 (m)74.83.79 (m)74.73.67 (m)85.6
4′′′4.27 a74.14.19 a74.44.18 a74.33.71 a 82.6
5′′′4.24 a,67.84.38 (m)67.84.38 a67.83.74 a71.6
6′′′1.68 (3H, d, 6.6)17.61.63 (3H, d, 6.6)17.51.64 (3H, d, 6.6)17.51.68 (3H, d, 6.0)18.4
3′′′-OMe3.51 (3H, s)55.53.42 (3H, s)55.33.41 (3H, s)55.33.91 (3H, s)60.3
β-D-Glcβ-D-Glcβ-D-Glcβ-D-Glc
1′′′′4.96 (d, 7.8)105.14.94 (d, 7.8)105.24.93 (br d, 8.0)105.25.12 (d, 7.9)104.5
2′′′′4.00 a75.04.00 (m)75.13.99 a75.04.01 (dd, 8.2, 7.8)75.6
3′′′′4.23 a78.34.20 a78.34.19 a78.34.21 a78.4
4′′′′4.19 a71.64.17 a71.64.18 a71.54.19 a71.6
5′′′′3.94 a78.03.89 (m)78.03.88 a77.93.95 (m)78.0
6′′′′4.52 (dd, 11.4, 2.5),
4.34 (dd, 11.4, 5.5)
62.84.48 (dd, 11.4, 2.4),
4.33 a
62.84.48 (dd, 11.5, 2.4),
4.32 (dd, 11.5, 5.5)
62.74.54 (dd, 11.5, 2.5),
4.34 a
62.8
a Overlapped with other signals. b 600 MHz, c 400 MHz, d 150 MHz, e 100 MHz. J values in Hz. Cym = cymaropyranose, Dgt = digitoxopyranose, Dgn = diginopyranose, The = thevetopyranose, Ole = oleandropyranose, Glc = glucopyranose.
Table 2. 1H and 13C NMR data in C5D5N for compounds 914.
Table 2. 1H and 13C NMR data in C5D5N for compounds 914.
NO.91011121314
δH bδC dδH bδC dδH bδC dδH bδC dδH bδC eδH bδC e
12.18 a, 1.38 a44.52.37 a, 2.33 a51.52.37 a, 2.33 a51.52.18 a, 1.37 a44.62.36 a, 2.33 a51.12.89 (d, 12.7), 2.25 a47.8
23.94 (m)69.9205.7205.63.95 (m)69.9205.7210.6
33.60 a84.44.75 (dd, 12.7, 7.0)78.04.75 a77.93.60 a84.54.74 (dd, 12.4, 7.0)77.94.50 (t, 3.5)78.7
42.52 (dd, 14.0, 4.7), 2.43 (d, 14.0)37.22.95 (dd, 14.2, 7.0), 2.63 (m)39.42.95 (dd, 13.9, 7.0), 2.62 (m)39.42.52 (dd, 14.0, 5.0), 2.41 a 37.32.93 (dd, 14.2, 7.0), 2.62 (m)39.42.82 (m), 2.78 a39.3
5139.9137.6137.6140.0137.6136.9
65.37 (m)120.05.44 (m)122.05.45 (m)122.05.36 (m)120.15.45 (m)122.05.41 (m)122.0
73.14 (dt 21.2, 3.9), 2.72 (d, 21.2)25.53.15 (dt, 21.3, 3.8), 2.75 (br d, 21.3)25.63.14 (dt, 21.0, 3.8), 2.74 (br d, 21.0)25.63.14 (br d, 21.0), 2.72 (br d, 21.0)25.63.14 (dt, 21.0, 4.0), 2.75 (br d, 21.0)25.63.10 (dt, 21.0, 3.4) 2.70 (br d, 21.0)25.5
8103.4102.5102.5103.5102.55.28 a103.0
92.17 a44.72.34 a44.52.34 a44.52.17 a44.82.34 a44.52.44 (dd, 8.8, 8.1)44.4
1038.343.243.238.443.242.9
111.64 (m), 1.31 a19.91.51 a, 1.22 a19.81.53 a, 1.20 a19.81.64 a, 1.27 a20.01.52 (m), 1.22 (m)19.81.52 (m), 1.22 (m)19.9
121.91 a, 1.40 a31.51.92 a, 1.42 (m)31.41.92 a, 1.42 (m)31.41.90 a, 1.39 a31.61.92 a, 1.42 a31.41.93 a, 1.42 a31.4
1353.453.653.553.553.553.6
14152.7153.4153.3152.8153.3153.2
154.24 a, 3.79 (dd, 10.9, 4.4)72.04.25 (d, 11.0), 3.78 (dd, 11.0, 4.3)72.14.25 a, 3.79 (dd, 10.9, 4.3)72.14.24 a, 3.78 (dd, 10.7, 3.9) 72.14.24 a, 3.80 (dd, 10.9, 4.3)72.14.23 a, 3.78 (dd, 10.8, 4.3)72.1
164.76 (m)84.04.78 a84.34.76 a84.24.75 (m)84.14.78 (m)84.34.72 (m)84.3
172.81 (d, 8.0)63.22.82 (d,7.8)63.32.82 (d, 7.8)63.22.79 (d, 7.7)63.32.82 (d, 8.0)63.22.78 (d, 7.9)63.2
184.07 a, 4.00 (d, 8.8)76.34.04 (br d, 8.7), 3.98 (d, 8.7) 76.44.04 (br d, 8.8), 3.98 (d, 8.8) 76.34.07 (d, 8.8), 4.01 (d, 8.8)76.44.03 a, 4.00 a76.34.04 a, 3.98 a76.4
190.81 (3H, s)19.30.77 (3H, s)19.30.77 (3H, s)19.30.81 (3H, s)19.40.76 (3H, s)19.30.80 (3H, s)19.5
20117.9118.0118.0118.0118.0118.0
211.56 (3H, s)22.21.56 (3H, s)22.31.58 (3H, s)22.31.57 (3H, s) 22.31.56 (3H, s)22.31.56 (3H, s)22.3
β-D-Cymβ-D-Cymβ-D-Cymβ-D-Cymβ-D-Cymβ-D-Cym
1′5.18 (br d, 9.5)97.35.28 (1H, dd, 9.4, 1.7)95.65.29 (br d, 9.6)95.55.18 (br d, 9.6)97.45.26 (dd, 9.6, 1.6)95.5 5.18 (dd, 9.6, 1.7)97.2
2′2.32 a, 1.87 a36.52.38 a, 1.95 a36.22.37 a, 1.96 a36.22.33 (m), 1.87 a36.72.35 a, 1.93 a36.22.36 a, 1.88 a36.5
3′4.06 a77.54.07 a77.54.10 (m)77.54.09 a77.64.02 a77.54.02 a77.4
4′3.46 a82.63.51 a82.73.53 a82.73.50 (m) 82.73.45 a82.63.44 a82.8
5′4.22 a69.14.21 (m)69.14.23 a69.14.23 a69.24.16 a69.04.12 a69.2
6′1.34 (3H, d, 6.1)17.91.35 (3H, d, 6.2)18.21.34 (3H, d, 6.3)18.21.32 (3H, d, 6.4)18.01.31 (3H, d, 6.4)18.11.31 (3H, d, 6.2)18.1
3′-OMe3.57 (3H, s)58.43.56 (3H, s) 58.43.58 (3H, s)58.43.60 (3H, s)58.63.56 (3H, s)58.53.54 (3H, s)58.7
β-D-Cymβ-D-Cymβ-D-Dgtβ-D-Dgtβ-D-Cymβ-D-Cym
1′′5.05 (br d, 9.6)100.15.06 (1H, dd, 9.7, 1.6)100.25.35 (br d, 9.6)100.45.34 (br d, 9.6)100.55.05 (br d, 9.4)100.05.03 (br d, 9.4)100.1
2′′2.34 a, 1.76 (m) 35.52.36 a, 1.77 (m)35.62.42 a, 1.98 a39.42.41 a, 1.98 (m) 39.32.27 a, 1.73 (m)36.72.25 a, 1.72 (m)36.7
3′′3.73 (m)78.43.73 (d, 2.8)78.64.41 (m)68.34.42 (m)68.33.85 (m)77.43.84 (m)77.4
4′′3.51 a73.73.51 a73.93.57 a73.73.57 a73.73.40 a82.03.38 a81.9
5′′4.09 a70.64.09 a70.74.26 a70.14.27 a70.14.14 a69.04.11 a68.9
6′′1.52 (3H, d, 6.1)18.61.52 (3H, d, 6.3)18.71.57 (3H, d, 6.4)18.71.58 (3H, d, 6.4)18.71.32 (3H, d, 6.4)18.21.28 (3H, d, 6.3)18.2
3′′-OMe3.45 (3H, s)57.73.44 (3H, s) 57.93.56 (3H, s)58.33.55 (3H, s)58.2
α-L-Cymα-L-Cym
1′′′4.93 (br d, 2.5)98.64.92 (br d, 2.6)98.6
2′′′2.36 a, 1.79 (m)32.02.35 a, 1.78 (m)32.0
3′′′3.92 a73.13.93 a73.1
4′′′3.95 a78.73.96 a78.7
5′′′4.68 (m)64.94.67 (m)64.9
6′′′1.46 (3H, d, 6.4)18.21.46 (3H, d, 6.4)18.3
3′′′-OMe3.43 (3H, s)56.53.42 (3H, s)56.6
β-D-Glcβ-D-Glc
1′′′′4.99 (d, 7.8)102.04.99 (d, 7.8)102.0
2′′′′3.96 a75.03.97 a75.0
3′′′′4.22 a78.24.22 a78.2
4′′′′4.19 a71.54.20 a71.6
5′′′′3.97 a78.43.97 a78.4
6′′′′4.56 (dd, 11.0, 2.0), 4.37 (dd, 11.0, 5.5)62.74.56 (dd, 11.0, 2.0), 4.37 (dd, 11.0, 5.5)62.7
a Overlapped with other signals. b 600 MHz, d 150 MHz, e 100 MHz. J values in Hz. Cym = cymaropyranose, Dgt = digitoxopyranose, Glc = glucopyranose.
Table 3. Cytotoxicity data of compounds 114 a.
Table 3. Cytotoxicity data of compounds 114 a.
CompoundHL-60THP1PC-3
174.0857.4150.85
254.14>80
317.7843.1652.16
4>8061.61
554.0322.95
660.66>80
7>8064.43
852.3158.03
959.70>80
10>8050.98>80
1124.245.0822.75
1227.9836.90>80
1356.7232.7475.28
1450.4916.02>80
5-Fluorouracil9.935.8222.15
a Data expressed as IC50 values (μm). HL-60, human leukemic promyelocytic cell; THP-1, human acute monocytic leukemia cell line; PC-3, prostate cancer cell line.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, Y.-B.; Zhao, D.; Su, S.-S.; Chen, G.; Wang, H.-F.; Pei, Y.-H. Twelve New Seco-Pregnane Glycosides from Cynanchum taihangense. Molecules 2022, 27, 5500. https://doi.org/10.3390/molecules27175500

AMA Style

Wang Y-B, Zhao D, Su S-S, Chen G, Wang H-F, Pei Y-H. Twelve New Seco-Pregnane Glycosides from Cynanchum taihangense. Molecules. 2022; 27(17):5500. https://doi.org/10.3390/molecules27175500

Chicago/Turabian Style

Wang, Yu-Bo, Dan Zhao, Shan-Shan Su, Gang Chen, Hai-Feng Wang, and Yue-Hu Pei. 2022. "Twelve New Seco-Pregnane Glycosides from Cynanchum taihangense" Molecules 27, no. 17: 5500. https://doi.org/10.3390/molecules27175500

Article Metrics

Back to TopTop